Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Study of Eupenta Vaccine in Healthy Infants
NCT04056728Phase 4Unknown
- Sponsor
- LG Chem
- Start
- Sep 2019
- Primary completion
- Oct 2020
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 4 trial of diphtheria + tetanus + whole-cell pertussis + hepatitis b + haemophilus influenzae type b conjugate vaccine in diphtheria, Tetanus, pertussis, hepatitis B (HBV), Haemophilus influenzae type b infection (Hib), sponsored by LG Chem. Status: unknown.
02
Drugs
diphtheria + tetanus + whole-cell pertussis + hepatitis b + haemophilus influenzae type b conjugate vaccine
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT04056728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04056728.